US insurance companies may not pay for new diabetic devicesBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7234.536/d (Published 26 February 2000) Cite this as: BMJ 2000;320:536
- Fred Charatan
Although medical device companies in the United States are forging ahead in developing new, non-invasive blood and tissue glucose monitors, insurance companies are proving unwilling or unable to pay for many of them.
The most advanced non-invasive device is the GlucoWatch Monitor, made by Cygnus of Redwood City, California, which is worn like a wristwatch. It uses a low level electric current to induce reverse iontophoresis.
This allows the monitor to collect glucose samples from interstitial tissue (not …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial